MTOR and glioblastoma: In summary, our work not only uncovered the negative roles of MDHDH in GBM aggressiveness, metabolic reprogramming reversal and AMPK/mTOR pathway regulation but also implicated that MDHDH could act as a bridge to mediate autophagy-based and epigenetic-based therapies.